Mogrify has developed a proprietary direct cellular conversion technology, which makes it possible to transform (transmogrify) any mature human cell type into any other without going through a pluripotent stem cell- or progenitor cell-state.
In a collaboration with Sangamo, Mogrif’s cell conversion technology will be applied to generate regulatory T cells (Tregs) from pluripotent stem cells and embryonic stem cells. Sangamo aims to apply its ZFP gene engineering technology to Tregs as allogeneic cell therapies to treat inflammatory and autoimmune diseases.
Timeline
May 2021
Mogrify raises a $17,000,000 series A round from 24Haymarket, Astellas Venture Management, Darrin M Disley, Jonathan Milner and Parkwalk Advisors.
January 2020
Mogrify raises a $1,100,000 venture round.
October 14, 2019
Mogrify raises $3.7M in seed capital, appoints Dr. Darrin M. Disley, OBE as CEO, launches the Mogrify V2 and Epimogrify V1 platforms, and is raising an additional $16 million USD in the initial close of its Series A funding.
October 2019
Mogrify raises a $16,000,000 series A round from 24Haymarket, Ahren Innovation Capital, Parkwalk Advisors and University of Bristol Enterprise Fund.
February 2019
Mogrify raises a $3,700,000 seed round from 24Haymarket, Ahren Innovation Capital and Darrin M Disley.
Funding rounds
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Alex Keown
November 6, 2020
BioSpace
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
References
Is a
CompanyCompany attributes
Arthritis
Biotechnology
Biomedical engineering
Cell therapy
Autoimmune diseaseLocation
Cambridge, CambridgeshireCompany status
Active
Crunchbase
Parkwalk Advisors
Astellas Venture Management
Darrin M Disley
24Haymarket
Jonathan Milner
Ahren Innovation Capital
University of Bristol Enterprise FundTotal funding amount (USD)
37,800,000
Latest funding round date
May 2021
Competitors
BitbioLatest funding type
Series A roundOther attributes
Country
United KingdomCategories
Related Topics
Contributors
- 1
Jed Christiansen
Director of Product and Data at Golden || Founder - Seed-DB. - 2
Meredith Hanel
Medical Genetics PhD, following life science applications that improve the health of humans and our planet. - 3
Erin Scherfner
loading information... - 4
Dawson Sewell
Writing about startups. - 5
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 6
Aime Anne Nisay
QA Engineer of web and mobile applications